Multiple Myeloma
Multiple Myeloma
Advertisement
Alicia Michaelsen, BSN, RN, BMTCN®Multiple Myeloma | March 25, 2024
Alicia Michaelsen, BSN, RN, BMTCN, discusses the importance of raising awareness.
View More
Cecilia BrownMultiple Myeloma | March 18, 2024
The withdrawal comes 2 years after the FDA granted accelerated approval to the treatment.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | March 12, 2024
Oncology nurses must be able to quickly identify hypercalcemia because it can cause cardiac arrest or coma.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | March 12, 2024
Hypercalcemia is the most common oncologic emergency, which makes it critical to understand this electrolyte imbalance.
Cecilia BrownMultiple Myeloma | March 12, 2024
A new study shows why it's critical to assess patients for financial and time toxicity.
Cecilia BrownMultiple Myeloma | March 12, 2024
There is “no apparent” standard-of-care treatment regimen for these patients.
Cecilia BrownMultiple Myeloma | March 13, 2024
Learn how a team implemented professional interpretation services in an interactive, virtual pre-HSCT nutrition class.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | March 1, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses what the month means to her as a nurse.
Krystal Waldrup, BSN, RN, OCNNews | February 29, 2024
Learn how an institution started a standalone CAR-T cell therapy program without a pre-existing BMT program.
Cecilia BrownMultiple Myeloma | February 28, 2024
Researchers evaluated how the bispecific antibody compared to real-world physicians’ choice of therapy.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | March 4, 2024
Learn how treatment for the rare blood cancer has changed over the years and how to discuss the condition with patients.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As the care team members with the most patient contact, oncology nurses must understand shared decision-making.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | February 21, 2024
As patients may be considering or receiving anti-BCMA therapy, oncology nurses need to be able to explain this target.
Cecilia BrownMultiple Myeloma | January 31, 2024
Most patients who switched to a reduced frequency or reduced dose showed deepened or maintained responses to treatment.
Cecilia BrownMultiple Myeloma | February 5, 2024
Previous analyses have suggested system-level and patient-level barriers limit patient access to precision oncology options.
Cecilia BrownMultiple Myeloma | March 12, 2024
A nurse navigator assessed financial and transportation barriers, coordinated resources, and performed outreach.
Cecilia BrownMultiple Myeloma | January 31, 2024
Previous research showed that only 10% of older patients with hematological malignancies received a geriatric assessment.
Cecilia BrownMultiple Myeloma | February 14, 2024
It was important to develop the model because outcomes are heterogenous, with overall survival ranging from months to years.
Cecilia BrownHematology & Blood Cancer | January 15, 2024
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Cecilia BrownHematology & Blood Cancer | January 4, 2024
Anastasia Marie Santiago, DNP, APRN, FNP-BC, AOCNP, shares her experiences and several critical pieces of advice.
Advertisement
Advertisement
Advertisement